Magargal L E, Kimmel A S, Sanborn G E, Annesley W H
Ophthalmic Surg. 1986 Apr;17(4):240-6.
Two hundred forty-six eyes with temporal branch retinal vein obstruction (TBRVO) were studied prospectively. Of the 85 eyes not receiving laser treatment, 35 (41%) presented with greater than or equal to 20/50 vision and 89% remained in this group; whereas, 29 eyes (34%) presented with less than or equal to 20/200 vision and only 17% improved. Of the 161 eyes receiving laser, 40 (25%) had greater than or equal to 20/50 vision pre-treatment and 75% remained in this group; whereas, 64 eyes (40%) had less than or equal to 20/200 vision pre-treatment and 50% improved. The average final VA (20/70 vs 20/100), risk of developing neovascularization in ischemic TBRVO (3% vs 34%) and risk of vitreous hemorrhage in proliferative TBRVO (10% vs 57%) were all significantly better in treated eyes (p less than or equal to 0.01).
对246例颞支视网膜静脉阻塞(TBRVO)患者的眼睛进行了前瞻性研究。在85只未接受激光治疗的眼睛中,35只(41%)视力大于或等于20/50,且89%的患者仍保持在该视力水平;而29只(34%)视力小于或等于20/200,只有17%的患者视力有所改善。在161只接受激光治疗的眼睛中,40只(25%)治疗前视力大于或等于20/50,75%的患者仍保持在该视力水平;而64只(40%)治疗前视力小于或等于20/200,50%的患者视力有所改善。治疗组患者的平均最终视力(20/70对20/100)、缺血性TBRVO发生新生血管的风险(3%对34%)以及增殖性TBRVO发生玻璃体出血的风险(10%对57%)均明显更好(p≤0.01)。